| Avanos Medical (AVNS) International Revenue in Focus: Trends and Expectations |
Explore Avanos Medical's (AVNS) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock. |
zacks.com |
2025-05-13 14:22:18 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for May 9th |
AVNS, BCC and AMPY have been added to the Zacks Rank #5 (Strong Sell) List on May 9, 2025. |
zacks.com |
2025-05-09 11:55:31 |
Czytaj oryginał (ang.) |
| AVNS Stock Gains Post Q1 Earnings & Revenue Beat, Gross Margin Down |
Strength in Avanos' SNS segment drives its first-quarter 2025 performance despite global macroeconomic challenges. |
zacks.com |
2025-05-07 17:50:34 |
Czytaj oryginał (ang.) |
| Avanos Medical, Inc. (AVNS) Q1 2025 Earnings Call Transcript |
Avanos Medical, Inc. (NYSE:AVNS ) Q1 2025 Earnings Conference Call May 6, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy and Corporate Development Dave Pacitti - Chief Executive Officer Jason Pickett - Interim Chief Financial Officer and Treasurer Conference Call Participants Rick Wise - Stifel Daniel Stauder - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos First Quarter 2025 Earnings Call. [Operator Instructions] This call is being recorded on Tuesday, May 6, 2025. |
seekingalpha.com |
2025-05-06 18:38:14 |
Czytaj oryginał (ang.) |
| Avanos Medical (AVNS) Q1 Earnings and Revenues Top Estimates |
Avanos Medical (AVNS) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.22 per share a year ago. |
zacks.com |
2025-05-06 13:25:57 |
Czytaj oryginał (ang.) |
| Avanos Medical, Inc. Announces First Quarter 2025 Results |
ALPHARETTA, Ga. , May 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported first quarter 2025 financial results. |
prnewswire.com |
2025-05-06 11:00:00 |
Czytaj oryginał (ang.) |
| Avanos Medical, Inc. to Webcast Conference Call Discussing First Quarter 2025 Financial Results |
ALPHARETTA, Ga. , April 28, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the first quarter 2025 on Tuesday, May 6 at 9 a.m. |
prnewswire.com |
2025-04-28 11:47:00 |
Czytaj oryginał (ang.) |
| AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK |
Avanos takes direct control of MIC-KEY sales in the UK, enhancing market presence, customer engagement and service efficiency, starting July 2025. |
zacks.com |
2025-04-03 12:55:34 |
Czytaj oryginał (ang.) |
| Avanos Expands Direct Operations for MIC-KEY* Enteral Feeding Products in the UK starting July 2025 |
ZAVENTEM, Belgium , April 2, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) a global medical technology company, today announced that it will take direct responsibility for the sales and distribution of its MIC-KEY enteral feeding products in the United Kingdom, effective 25 July 2025. This strategic move reflects Avanos' commitment to prioritizing customer needs, enhancing product availability into the future, and providing a seamless experience for healthcare providers and patients. |
prnewswire.com |
2025-04-02 11:00:00 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for March 24th |
AVNS, AIRS and AMPH have been added to the Zacks Rank #5 (Strong Sell) List on March 24, 2025. |
zacks.com |
2025-03-24 08:30:22 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for March 18th |
AVNS, CARS and CABO have been added to the Zacks Rank #5 (Strong Sell) List on March 18, 2025. |
zacks.com |
2025-03-18 11:00:29 |
Czytaj oryginał (ang.) |
| Avanos Medical Announces Appointment of David Pacitti as Chief Executive Officer |
ALPHARETTA, Ga. , March 17, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025. |
prnewswire.com |
2025-03-17 09:30:00 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for March 3rd |
AVNS, CSX and STZ have been added to the Zacks Rank #5 (Strong Sell) List on March 3, 2025. |
zacks.com |
2025-03-03 09:50:23 |
Czytaj oryginał (ang.) |
| AVNS Stock Gains Post Q4 Earnings & Revenue Beat, Margins Contract |
Strength in Avanos' Digestive Health segment drives its fourth-quarter 2024 performance despite global macroeconomic challenges. |
zacks.com |
2025-02-27 12:46:26 |
Czytaj oryginał (ang.) |
| Avanos Medical Inc. (AVNS) Q4 2024 Earnings Call Transcript |
Avanos Medical Inc. (NYSE:AVNS ) Q4 2024 Earnings Conference Call February 26, 2025 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy & Corporate Development Michael Greiner - Interim Chief Executive Officer Conference Call Participants Danny Stauder - Citizens GMP Operator Good morning ladies and gentlemen. Welcome to the Avanos Fourth Quarter 2024 Earnings Call. |
seekingalpha.com |
2025-02-26 14:41:05 |
Czytaj oryginał (ang.) |
| Avanos Medical (AVNS) Q4 Earnings and Revenues Surpass Estimates |
Avanos Medical (AVNS) came out with quarterly earnings of $0.43 per share, beating the Zacks Consensus Estimate of $0.40 per share. This compares to earnings of $0.36 per share a year ago. |
zacks.com |
2025-02-26 11:25:29 |
Czytaj oryginał (ang.) |
| Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2024 Results |
ALPHARETTA, Ga. , Feb. 26, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2024 results. |
prnewswire.com |
2025-02-26 09:00:00 |
Czytaj oryginał (ang.) |
| Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results |
ALPHARETTA, Ga. , Feb. 19, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2024 on Wednesday, Feb. 26 at 9 a.m. |
prnewswire.com |
2025-02-19 10:54:00 |
Czytaj oryginał (ang.) |
| Avanos Medical (AVNS) Soars 7.2%: Is Further Upside Left in the Stock? |
Avanos Medical (AVNS) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term. |
zacks.com |
2025-01-28 12:16:28 |
Czytaj oryginał (ang.) |
| Reasons to Hold Avanos Medical Stock in Your Portfolio Now |
AVNS' strong product line and focus on R&D raise optimism about the stock. |
zacks.com |
2025-01-23 10:50:22 |
Czytaj oryginał (ang.) |
| Avanos Medical, Inc. to Present at the 43rd Annual J.P. Morgan Healthcare Conference |
ALPHARETTA, Ga. , Jan. 6, 2025 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will present at the 43rd Annual J.P. |
prnewswire.com |
2025-01-06 10:54:00 |
Czytaj oryginał (ang.) |
| New Strong Sell Stocks for December 11th |
AVNS, BATRK and ELV have been added to the Zacks Rank #5 (Strong Sell) List on December 11, 2024. |
zacks.com |
2024-12-11 06:50:18 |
Czytaj oryginał (ang.) |
| Avanos Medical, Inc. to Present at the Stifel 2024 Healthcare Conference |
ALPHARETTA, Ga. , Nov. 12, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in an analyst-led fireside chat at the Stifel 2024 Healthcare Conference at the Lotte New York Palace in New York on Tuesday, Nov. 19 at approximately 3:35 p.m. |
prnewswire.com |
2024-11-12 14:07:00 |
Czytaj oryginał (ang.) |
| ON-Q* Elastomeric Infusion Pump and ambIT* Disposable Electronic Infusion Pump to Receive Separate Payment Under NOPAIN Act Starting January 1, 2025 |
ALPHARETTA, Ga. , Nov. 11, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has issued its final Medicare Hospital Outpatient Prospective Payment System (OPPS) and Medicare Ambulatory Surgical Center (ASC) Payment System rule for 2025. |
prnewswire.com |
2024-11-11 11:38:00 |
Czytaj oryginał (ang.) |
| Avanos Medical, Inc. to Present at the UBS Healthcare Conference 2024 |
ALPHARETTA, Ga. , Nov. 8, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, interim chief executive officer, will participate in a fireside chat at the UBS 2024 Healthcare Conference on Tues. |
prnewswire.com |
2024-11-08 18:16:00 |
Czytaj oryginał (ang.) |
| Avanos Medical Launches New CORGRIP® SR |
Advancement to reduce dislodgement in feeding tube retention systems ALPHARETTA, Ga. , Nov. 5, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced the launch of its newly designed CORGRIP SR Nasogastric/Nasointestinal Tube Retention System, further expanding its comprehensive Enteral Feeding portfolio. |
prnewswire.com |
2024-11-05 09:00:00 |
Czytaj oryginał (ang.) |
| Are Investors Undervaluing Avanos Medical (AVNS) Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2024-10-31 12:45:34 |
Czytaj oryginał (ang.) |
| Avanos Q3 Earnings Meet Estimates, Sales Miss, Gross Margin Contracts |
Avanos Medical, Inc. AVNS reported third-quarter 2024 adjusted earnings per share (EPS) from continuing operations of 36 cents, up 20% year over year. The bottom line met the Zacks Consensus Estimate. |
zacks.com |
2024-10-31 11:46:27 |
Czytaj oryginał (ang.) |
| Avanos Medical Inc. (AVNS) Q3 2024 Earnings Call Transcript |
Avanos Medical Inc. (NYSE:AVNS ) Q3 2024 Results Conference Call October 30, 2024 9:00 AM ET Company Participants Scott Galovan - Vice President of Strategy & Corporate Development Gary Blackford - Chairman Michael Greiner - Senior VP, CFO & Chief Transformation Officer Conference Call Participants Kristen Stewart - CL King Danny Stauder - Citizens JMP Operator Good morning, ladies and gentlemen, and welcome to the Avanos Medical, Avanos Third Quarter 2024 Earnings Call. [Operator Instructions] This call is being recorded on Wednesday, October 30, 2024. |
seekingalpha.com |
2024-10-30 17:28:07 |
Czytaj oryginał (ang.) |
| Avanos Medical (AVNS) Q3 Earnings Meet Estimates |
Avanos Medical (AVNS) came out with quarterly earnings of $0.36 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.30 per share a year ago. |
zacks.com |
2024-10-30 11:01:33 |
Czytaj oryginał (ang.) |
| Avanos Medical, Inc. Announces Third Quarter 2024 Results, retirement of CEO |
ALPHARETTA, Ga. , Oct. 30, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported third quarter 2024 financial results and announced the retirement of its CEO, Joe Woody. |
prnewswire.com |
2024-10-30 08:45:00 |
Czytaj oryginał (ang.) |
| Avanos Medical, Inc. to Webcast Conference Call Discussing Third Quarter 2024 Financial Results |
ALPHARETTA, Ga. , Oct. 23, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the third quarter 2024 on Wednesday, Oct. 30 at 9 a.m. |
prnewswire.com |
2024-10-23 10:19:00 |
Czytaj oryginał (ang.) |
| Avanos Medical (AVNS) Upgraded to Strong Buy: What Does It Mean for the Stock? |
Avanos Medical (AVNS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy). |
zacks.com |
2024-10-17 17:01:16 |
Czytaj oryginał (ang.) |
| Should Value Investors Buy Avanos Medical (AVNS) Stock? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2024-10-09 14:45:22 |
Czytaj oryginał (ang.) |
| Reasons to Add Avanos Medical Stock in Your Portfolio Now |
AVNS's strong product line and focus on R&D raise optimism about the stock. |
zacks.com |
2024-10-03 17:51:11 |
Czytaj oryginał (ang.) |
| Are Investors Undervaluing Avanos Medical (AVNS) Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2024-09-19 14:41:15 |
Czytaj oryginał (ang.) |
| Why Avanos Medical (AVNS) is a Top Momentum Stock for the Long-Term |
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. |
zacks.com |
2024-09-13 14:56:16 |
Czytaj oryginał (ang.) |
| Avanos Medical Stock May Gain From Brand Partnership With NFL |
AVNS' GAME READY announces a paid partnership with NFL defensive end and San Francisco 49ers star, Nick Bosa. |
zacks.com |
2024-09-12 18:10:15 |
Czytaj oryginał (ang.) |
| Avanos Medical, Inc. to Present at the 2024 CL King Annual Best Ideas Conference |
ALPHARETTA, Ga. , Sept. 9, 2024 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Michael Greiner, senior vice president, chief financial officer, and chief transformation officer will participate in a fireside chat at CL King's virtual 22nd Annual Best Ideas Conference 2024 on Mon. |
prnewswire.com |
2024-09-09 14:54:00 |
Czytaj oryginał (ang.) |
| Is Avanos Medical (AVNS) Stock Undervalued Right Now? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2024-08-22 14:46:33 |
Czytaj oryginał (ang.) |
| Should Value Investors Buy Avanos Medical (AVNS) Stock? |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. |
zacks.com |
2024-08-05 14:46:25 |
Czytaj oryginał (ang.) |